AAV Gene Therapy Capsids
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
83
NCT06346600
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Phase: N/A
Role: Lead Sponsor
Start: Apr 2, 2024
Completion: Mar 31, 2031
Loading map...